Ltslohmann.com Website Review

LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (“TTS”) and Oral Thin Films (“OTF”) for the pharmaceutical industry. Using a patch to protect the wound and accelerate healing is well known – but patches can achieve much more than this. As transdermal thera*eutic systems, they can replace tablets or injection solutions and release the active substance into the body via the skin, offering an innovative, straightforward and highly tolerable form of therapy. LTS is your B2B partner, without its own products in the pharmaceuticals market. LTS develops and manufactures transdermal thera*eutic systems (TTS) and oral thin films (OTF) based on your specific active substance. Our solutions make it possible for you to broaden your product portfolio or to enable a substance to be used for therapy. From feasibility studies to pharmaceutical development and process development to production and packaging, LTS offers all the services you need from one partner. There are currently 20 known substances that can be applied transdermally. LTS offers twelve of these substances as transdermal thera*eutic systems, making many patients’ lives easier. In cooperation with its partners from the pharmaceutical industry, LTS has set milestones in terms of innovation. LTS’s many successful products are proof of this. LTS is the market leader in transdermal thera*eutic systems (TTS) and oral thin films (OTF). Founded in 1984, LTS has become a strong and innovative specialist medium-sized company. As a global player, LTS is an attractive employer that is aware of its social responsibilities LTS’s research and development focuses on two new technologies to complement and expand the potential of alternative drug delivery systems. In addition to the permanent further development of LTS TTS and LTS OTF technologies, the company also develops innovative The development of new pharmaceutical drugs is a lengthy and complex process in which not every highly promising active substance